These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 20494894)

  • 21. Therapeutic strategies for heart failure in cardiorenal syndromes.
    House AA; Haapio M; Lassus J; Bellomo R; Ronco C
    Am J Kidney Dis; 2010 Oct; 56(4):759-73. PubMed ID: 20557988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modifications to advanced life support in renal failure.
    Alfonzo AV; Simpson K; Deighan C; Campbell S; Fox J
    Resuscitation; 2007 Apr; 73(1):12-28. PubMed ID: 17187916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardio-renal syndrome type 3: epidemiology, pathophysiology, and treatment.
    Chuasuwan A; Kellum JA
    Semin Nephrol; 2012 Jan; 32(1):31-9. PubMed ID: 22365160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The cardio-renal anemia syndrome: what is it? With a focus on congestive heart failure].
    Petersen H; Jensen KE; Haghfelt TH
    Ugeskr Laeger; 2006 May; 168(19):1864-7. PubMed ID: 16756804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogenesis of cardiorenal syndrome type 1 in acute decompensated heart failure: workgroup statements from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI).
    Haase M; Müller C; Damman K; Murray PT; Kellum JA; Ronco C; McCullough PA
    Contrib Nephrol; 2013; 182():99-116. PubMed ID: 23689658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical factors affecting serum potassium concentration in cardio-renal decompensation syndrome.
    Ueno H; Yoshimura M; Nakayama M; Yamamuro M; Nishijima T; Kusuhara K; Nagayoshi Y; Kojima S; Kaikita K; Sumida H; Sugiyama S; Ogawa H
    Int J Cardiol; 2010 Jan; 138(2):174-81. PubMed ID: 18804879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural course and risk factors for impaired renal function during the first year after heart transplantation.
    Jokinen JJ; Tikkanen J; Kukkonen S; Hämmäinen P; Lommi J; Sipponen J; Lemström KB
    J Heart Lung Transplant; 2010 Jun; 29(6):633-40. PubMed ID: 20347339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Combined cardio-renal failure: a key factor in heart failure progression and therapy].
    Caramelo C; Gil P
    Rev Esp Cardiol; 2006 Feb; 59(2):87-90. PubMed ID: 16540027
    [No Abstract]   [Full Text] [Related]  

  • 29. Influence of renal function on the use of guideline-recommended therapies for patients with heart failure.
    Heywood JT; Fonarow GC; Yancy CW; Albert NM; Curtis AB; Stough WG; Gheorghiade M; McBride ML; Mehra MR; O'Connor CM; Reynolds D; Walsh MN
    Am J Cardiol; 2010 Apr; 105(8):1140-6. PubMed ID: 20381667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic encephalopathy as a complication of renal failure: mechanisms and mediators.
    Fraser CL; Arieff AI
    New Horiz; 1994 Nov; 2(4):518-26. PubMed ID: 7804801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heart failure and dialysis: new thoughts and trends.
    Arora N; Dellsperger KC
    Adv Perit Dial; 2007; 23():72-6. PubMed ID: 17886607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of biomarkers in the diagnosis and management of cardio-renal syndromes.
    Cruz DN; Fard A; Clementi A; Ronco C; Maisel A
    Semin Nephrol; 2012 Jan; 32(1):79-92. PubMed ID: 22365166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Renal failure is an independent predictor of mortality in hospitalized heart failure patients and is associated with a worse cardiovascular risk profile].
    Grigorian Shamagian L; Varela Román A; Pedreira Pérez M; Gómez Otero I; Virgós Lamela A; González-Juanatey JR
    Rev Esp Cardiol; 2006 Feb; 59(2):99-108. PubMed ID: 16540030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decompensated heart failure in the setting of kidney dysfunction: a community-wide perspective.
    Ismailov RM; Goldberg RJ; Lessard D; Spencer FA
    Nephron Clin Pract; 2007; 107(4):c147-55. PubMed ID: 17957126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Worsening renal function in children hospitalized with decompensated heart failure: evidence for a pediatric cardiorenal syndrome?
    Price JF; Mott AR; Dickerson HA; Jefferies JL; Nelson DP; Chang AC; O'Brian Smith E; Towbin JA; Dreyer WJ; Denfield SW; Goldstein SL
    Pediatr Crit Care Med; 2008 May; 9(3):279-84. PubMed ID: 18446113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Quality of life in patients with combined treatments for heart failure].
    Nacca RG; Caliendo A; Simonelli R; Violi F; Lamberti F; Rossi G; Mantella D; Iorio L
    G Ital Nefrol; 2006; 23 Suppl 34():S77-82. PubMed ID: 16634002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardio-renal syndromes.
    Goh CY; Ronco C
    J Ren Care; 2010 May; 36 Suppl 1():9-17. PubMed ID: 20586895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal function as a predictor of prognosis in chronic heart failure.
    Hillege H; Van Gilst W; de Zeeuw D; van Veldhuisen DJ
    Heart Fail Monit; 2002; 2(3):78-84. PubMed ID: 12634888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impaired renal function in acute myocardial infarction.
    Lekston A; Kurek A; Tynior B
    Cardiol J; 2009; 16(5):400-6. PubMed ID: 19753517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.